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INTRODUCTION 
 
Acute myocardial infarction (AMI) can be defined in different ways in 
relation to its clinical, elettrocardiographic, echocardiographic, 
biochemical and phatologic characteristics1; instead, it is widely 
accepted that the term myocardial infarction reflects the death of 
cardiac myocytes caused by prolonged ischaemia. 
An acute coronary syndrome (ACS) is nearly always caused by a 
sudden reduction in coronary blood flow caused by atherosclerosis 
with trombosis superimposed with or without concomitant 
vasoconstriction2. 
In the presence of clinically appropriate symptoms two categories of 
patients may be encountered: patients with persistent ST segment 
elevation or (or so presumed) new left bundle branch block (STEMI) 
and patients without ST segment elevation, i.e. ST segment depression 
or T wave abnormalities3 (NSTEMI). 
Persistent ST segment elevation generally reflects acute total coronary 
occlusion and the great majority of these patients show a typical rise 
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of myocardial necrosis biomarkers and progress to Q-wave 
myocardial infarction; the therapeutic goal is rapid, complete and 
sustained recanalization of infarct vessel by fibrinolytic treatment or 
primary percutaneous coronary intervention (PCI)3. 
Echocardiography is a quick, repeatable, non invasive diagnostic 
technique playing a pivotal role in the diagnosis and follow-up of 
ACS. Echocardiography allows to estimate severity and extension of 
coronary artery disease and to obtain prognostic informations that may 
influence the terapheutic choices. An accurate analysis of left 
ventricular function, global and regional, is useful to evaluate the 
anatomical injury and the complications of AMI.  
In patients with STEMI, several randomized clinical trials have 
demonstrated an improved residual left ventricular function and a 
better clinical outcome after mechanical4,5 [PCI or, in a limited 
number of patients, coronary artery by-pass surgery (CABG)] or 
pharmachological6-8 (fibrinolysis) restoration of patency of the infarct 
vessel and myocardial tissue reperfusion. 
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The degree of recovery of left ventricular function after STEMI is 
related to the quickness and effectiveness of coronary reperfusion and 
consequently, to real infarct size9.  
The necessary time for a complete functional recovery really differ 
among patients and, in a single patient, is variable depending on  
myocardial segments. Several studies with repeated echocardiograms 
have demonstrated the restoration of left ventricular function since 24 
hours to ten days after coronary reperfusion; although, in the presence 
of stunned myocardium, three or four weeks may be necessary10.  
Echocardiography is important for the evaluation of left ventricular 
remodeling after ACS both during acute phase, and short and long 
term follow up; in fact, after effective coronary reperfusion, left 
ventricle dimensions are constant or reduced in the first three months 
after STEMI, while increase in patients that have not received an 
effective myocardial tissue reperfusion11. The patency of the infarct 
vessel is also linked to the improvement of regional function and to 
the reduction of dilatation of left ventricle since one to six months 
from symptoms onset12,13.  
 6 
Prognosis after AMI is related to the severity of left ventricular 
systolic impairment (infarct size) and to the presence and extension of 
residual myocardial ischemia14; in facts, an infarcted area of more than 
35% of whole left ventricle identifies patients at high risk of further 
events (reinfarction and death), with a percentage of mortality of 50% 
in the first month after AMI15.  
Several multivariate analyses have demonstrated that wall motion 
score index (WMSI) and left ventricle ejection fraction (LVEF) are 
important predictors of major adverse cardiovascular events (MACEs) 
and provide an accurate risk assessment (even more than 
haemodinamic parameters16-20). After STEMI, high values of WMSI 
identify patients at high risk of early in-hospital death, heart failure 
and fatal arrhythmias21.   
Left ventricle ejection fraction (LVEF), expression of global systolic 
function, is another very reliable parameter for long-term prognosis 
after AMI; in a population of 512 AMI patients, end-systolic area and 
left ventricle systolic function calculated on the basis of 
echocardiogram performed eleven days and one year after symptoms 
onset, were the stronger predictors of death and MACEs22.  
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Another important relief during the acute phase of AMI is the 
presence of hyperkinesis of myocardial segments not related to the 
infarct vessel; the absence of compensatory hyperkinesis is expression 
of multivessel coronary disease21,23,24 and is associated with an higher 
incidence of death, reinfarction and heart failure25. 
Actually, evaluation of left ventricular function can be performed with 
several echocardiographic methods: M-mode, two dimensional (2D) 
and Doppler [pulsed-wave (PW), continuous-wave (CW) and color] 
echocardiography, three dimensional (3D) echocardiography, 
backscatter, automatic border detection (ABD) and left ventricular 
opacification (LVO), color kinesis and tissue doppler imaging (TDI). 
Echocardiographist experience (operator-dependence) partially limits 
the use of this tecnique in the diagnosis, risk assessment and follow up 
of AMI.    
The increasing potentiality and flexibility of digital techniques are 
only partially utilized in acquisition, recording and off-line analysis of 
echocardiographic data, but it is easy to forecast a future dominant 
role of these methods in ultrasonic imaging.  
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The achievement of concrete progress in real-time echocardiographic 
imaging is due to a better comprehension of interactions between 
ultrasounds and tissues and to a better knowledge of formation, 
enhancement, analysis and quantification of ultrasonographic images.  
The interest in the availability of a quantitative method using an 
echocardiogram can be attributed to three main reasons: a) qualitative 
methods for the appraisal of left ventricular function are subjective 
and difficult to reproduce, b) a wide inter-operator variability in 
identifying events that materialize in a short period of time (< 80 
msec) and finally, c) it is extremely difficult to single out the onset 
and duration of two or more occurrences that take place 
simultaneously. 
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AIM 
 
Aim of the study were the validation and use of a new ultrasonic 
software for semi-automatic evaluation of global and regional left 
ventricular function in patients with STEMI. 
Moreover, this software was used to analyze the myocardial 
deformation (strain) and systolic and diastolic local velocities at 
infarcted and peri-infarcted region level; the aim of this evaluation 
was to identify the most important functional parameters for short and 
long term prognosis after STEMI. 
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MATERIALS AND METHODS 
 
Study population 
We analyzed 39 patients (mean age 59 ± 13 years, 76.9% men), 
admitted to the intensive coronary care unit of the Cardiac, Thoracic 
and Vascular Department of Pisa University Hospital with a diagnosis 
of STEMI. 
STEMI was defined according to the European Society of 
Cardiology/American College of Cardiology and American Heart 
Association/American College of Cardiology criteria1,26.  
The selection did not require the approval of the Institutional Ethical 
Committee because patients’ name were not revealed and 
echocardiographic evaluation was performed within our standard 
diagnostic method without any additional procedure for the patient. 
All patients, however, were informed about and agreed to data 
collection and study execution. All available clinical data were 
collected and stored in an appropriate database. 
Inclusion criteria of study patients were: 
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 a prior diagnosis of STEMI; 
  a TIMI-3 (angiographic evidence of grade 3 coronary flow 
proposed by the Thrombolysis in Myocardial Infarction study group) 
flow of the infarct-related coronary artery after primary or rescue PCI;  
 an adequate acoustic window. 
Patients with malignancies, sepsis, immunologic disease, chronic renal 
failure (serum creatinine ≥ 2.5 mg/dl), advanced liver disease, central 
nervous system damage, severe anemia (Hb ≤ 10 g/dl) and aged more 
than 85 years were excluded.   
77% (31 patients) and 13% (8 patients) were treated with primary and 
rescue PCI respectively. Twenty-three, 5 and 11 patients showed one-, 
two, and three-vessel coronary disease respectively; a complete 
myocardial revascularization (during the first week after STEMI) was 
performed in 9 out of 16 patients with multivessel coronary disease. 
After initial treatment (primary or rescue PCI), medical long-term 
therapy was administered according to clinical findings and physician 
judgment. 
Briefly, aspirin, clopidogrel, angiotensin-converting enzyme 
inhibitors, 3-hydroxy-3-methylglutaryl coenzime A reductase 
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inhibitors (statins) and β-blockers were administered as standard 
therapy to all patients (except contraindications). 
 
Study procedures 
All study patients were submitted to conventional echocardiography 
[M-mode, 2D and Doppler (PW, CW and color)] performed with a 
“Sequoia” echograph equipped with “4S” transducer at intensive 
coronary care unit admittance time [time 0 (t0)], three days [time 1 
(t1)] and six days [time 2 (t2)] from symptoms onset.  
We obtained mono dimensional echocardiographic images by short 
and long axis parasternal view and two dimensional 
echocardiographic images by two, four and five apical chamber views. 
Left ventricular diameters, interventricular septum and posterior wall 
thickness were measured according to the American Society of 
Echocardiography criteria27; end-diastolic and end-systolic volumes 
and global ejection fraction of left ventricle were obtained with 
Simpson’s rule formula28. 
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Left ventricular mass (LVM) was calculated with Devereux’s formula 
(Penn Convention)29, indexed for body surface (LVMibs) and height 
(LVMih)30,31. 
We evaluated PW Doppler parameters of transmitral flow velocity: E 
peak (velocity peak of transmitral flow in early diastole), A peak 
(velocity peak of transmitral flow during atrial systole), E/A ratio, 
mitral acceleration time (from baseline to E peak), mitral deceleration 
time (from E peak to baseline) and isovolumetric relaxation time 
(IVRT).  
Regional wall motion was studied after subdivision of left ventricle in 
16 segments according to the American Society of Echocardiography 
Guidelines27.  
We attribute to each segment a systolic wall thickening score as 
follow:  
 normokinesia (point 1);  
 hypokinesia (points 2); 
 akinesia (points 3); 
 dyskinesia (points 4).  
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The degree of wall motion abnormality was categorized adding up the 
score of each segment and dividing the result by total number of 
evaluated segments [according to wall motion score index (WMSI)]32. 
Two dimensional echocardiographic images, obtained by 2,4,5 apical 
chamber views, were transferred to a personal computer and analyzed 
off-line with a new software “DIOGENE” (AMID technology, Italy). 
“DIOGENE” provides global and regional LVEF evaluation through 
automatic border detection searching for each single points the 
maximum likelihood in the greyscale pattern over its neighbourhoods 
in the following frames. With “Diogene” the endocardial border is not 
determined by software, but it’s traced on a single frame by an expert 
operator and then it’s followed by software during the acquired 
cardiac cycles (Figure 1).  
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Figure 1: endocardial border layout on four apical chamber view. 
 
Using DIOGENE software, ambiguities of a total automatic approach 
are eliminated and a more careful check is possible. 
Endocardial border, drawed on a sigle frame, is identified by a series 
of single points and then it’s followed by software frame by frame. 
Calculation of traced points shifting, frame by frame during cardiac 
cycle, provides velocity vector data, peculiar of the motion of the 
same points33,34. 
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Unlike TDI, velocities calculated with “DIOGENE” are vectorial (two 
components) and not dependent on the ultrasonic angle of incidence. 
After definition of endocardial border in every frame, left ventricular 
volumes are calculated according to Simpson’s rule formula28, using 
64 equally-spaced disks between mitral floor and apex; with this 
method, “DIOGENE” is able to calculate both global and regional (16 
segments) systolic funtion of left ventricle.   
With the same technique it’s possible to investigate shifting and 
velocity vectors of points in the myocardial thickness, permitting the 
evaluation of two parameters, expression of average behaviour of wall 
thickness: strain and strain-rate, strictly linked to intramyocardial 
regional function34,35-39. 
Strain can be defined the deformation of an object indexed for its 
original shape. Strain of a monodimensional element is the ratio 
between change of its lenght after stress and its original lenght:          
∆ = (L - L0)/L0 (Figure 2). 
Strain of a two-dimensional element provides a monoaxial 
deformation along two orthogonal directions (Figure 21-2) and angular 
changes between these two axes (Figure 23-4). Strain of a two-
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dimensional element is a matrix with four indexes of deformation: two 
axial indexes and two angular indexes. This matrix is named tensor of 
deformation, with dimensions 2x2. 
Likewise strain of a three-dimensional element is delineated by nine 
indexes of deformation: three axial indexes and six angular indexes. 
Tensor of deformation have dimensions 3x3. 
In this study we considered the mono-dimensional deformation of a 
segment of left ventricular wall, belonging to the endocardial border 
traced point by point. 
Deformation of evaluated segments depends on their endocardial 
border location and time. If we know istant by istant start and end-
time segment deformation of the process we can define instantaneous 
deformation of the segment at t time such as:                                    
∆(t) = [L(t) – L(t0) ]/ L(t0).  
Moreover, the deformation at generical instant t can be expressed 
referring to the deformation at the immediately former instant:           
d∆(t) = [L(t+dt) – L(t) ]/ L(t).  
In this way, total deformation of a segment between two instants t0 – t1 
is the addition of single deformations at time intervals dt, in which the 
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interval t0 – t1 is resolved. Deformation so calculated is named natural 
deformation. Natural deformation is the most adequate to assess wide 
deformations like that during contraction and relaxation phases of 
cardiac cycle. 
Strain is a measure of the evaluated segment own activity and it is 
strictly linked to tissue effective contractility. 
 
Fi
gure 2: strain concept illustration. 
Strain rate is expression of the velocity of deformation and it’s 
measure unit is s-1; strain rate is calculated with the first derivative of 
deformation (strain) in the time.   
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Instantaneous strain rate is defined with the formula ε(t) = L’(t)/L(t): 
L’(t) is the deformation rate in the unit time and L(t) is the 
instantaneous lenght of evaluated segment. 
Strain rate is a measure of deformation in the time and it expresses 
shortening velocity for lenght of myofibril. Mean strain rate of a ∆r 
long segment at the instant t is defined with the following formula:                   
ε(t) = [v(r + ∆r) – v(r)]/ ∆r (Figure 3).    
 
Figure 3: strain rate concept illustration. 
Strain rate is zero for equal velocities of deformation in the two 
points; if the difference v(r+∆r) – v(r) is positive we have traction, 
otherwise we have compression. 
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In this way, in every patient after STEMI, we evaluated (by two, four 
and five apical chamber views) longitudinal strain of some regions of 
left ventricle (figure 4). 
Figure 4: longitudinal strain. 
In figure 5 we can observe an example of “Diogene” elaboration 
relative to intra-myocardial velocities and strain and strain rate 
behaviour. The curves of velocities (left ordinate in cm/s) and strain 
(right ordinate in %) time variation are reported in the low diagram; 
likewise the curves of velocities (left ordinate in cm/s) and strain rate 
(right ordinate in s-1) time variation are reported in the high diagram.    
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Figure 5: velocity, strain and strain rate time variations. 
With “Diogene” in all study patients we obtained end-diastolic 
volume (EDVc), end-systolic volume (ESVc), global ejection fraction 
(EFc) and regional ejection fraction (EFr) of the sixteen segments of 
left ventricle at t0, t1 and t2.  
In this way we identified myocardial areas with different behaviour:  
1- akinetic areas at t0, t1 and t2 (infarcted areas); 2- areas in wich EFr 
has improved (stunned myocardium); 3- areas in wich EFr has 
impaired (extension of ischemia); 4- “healthy” areas not injuried by 
ischemia.  
“Diogene” marks EFr with different values and colours: 1- EFr > 35% 
(green colour) is normal; 2- 15% < EFr < 35% (red colour) is 
expression of an hypokinetic segment; EFr < 15% (blue colour) is 
expression of akinesia (Figure 6). 
S peak 
E peak A peak velocity 
velocity 
strain 
strain 
rate 
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Figure 6: EFr calculation with “Diogene”. 
We studied intra-myocardial function of four areas, according to the 
values obtained with the software and the infarct coronary vessel: 1- a 
first infarcted area, akinetic or severely hypokinetic at all evaluation 
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times; 2- a second infarcted area, akinetic or severely hypokinetic, that 
only in nine patients showed an improvement of EFr with recovery of 
a normal value at t2; 3- a peri-infarcted area that showed a variable 
behaviour (improvement of EFr in 32 patients; light worsening in 
seven patients); 4- “healthy” area not injuried by ischemia, that 
showed a normal EFr at all evaluation times. 
In every area, “Diogene” provided strain and strain rate of evaluated 
segment and intra-myocardial velocities of each point selected for 
vectorial analysis (three points for every segment): S peak (systolic 
peak), E peak (proto-diastolic peak), A peak (end-diastolic peak)40-42 
(Figure 5).    
Patients of the study were divided onto two groups according to LVEF 
percent variation, obtained with conventional echocardiography: 
group 0 (20 patients, 80% men) with improved or constant ejection 
fraction and group 1 (19 patients, 74% men) with LVEF impairment.  
Inter-individual and intra-individual variability of values obtained 
with manual and semi-automatic method was very low. Evaluated 
parameters correlation was between 0.9 and 0.93 referring to inter-
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individual variability values and between 0.89 and 0.94 referring to 
intra-individual variability values.   
 
Statistical analysis    
Continuous variables are expressed as mean values and standard 
deviation. Analysis of variance for repeated measures and Tukey test 
were performed to evaluate echocardiographic parameters longitudinal 
differences (at t0, t1 and t2). Student’s t-test for not-paired data was 
performed for cross comparison between group 0 and group 1. We 
used analysis of variance for repeated measures according to Bland-
Altmann method to evaluate semi-automatic method repetibility, with 
an intra and inter-class coefficient.  
All calculation were performed using SPSS/PC+11-5 statistical 
software. 
Linear regression method was performed to obtain echocardiographic 
parameters correlation coefficients. The results were considered 
significant when the p value was < 0.05.     
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RESULTS 
 
Study patients were divided into two different groups in relation to  
LVEF values obtained with conventional echocardiography at t0, t1 
and t2 evaluation: group 0 patients showing improved or constant 
LVEF (t0 vs t2: 46.88 ± 4.26 vs 54.38 ± 5.85%; p < 0.05) (Figure 7),  
and group 1 patients showing  LVEF impairment (t0 vs t2: 54.00 ± 
6.48 vs 49.11 ± 2.57%; p < 0.01) (Figure 8) 
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Figure 7: time course variation of LVEF in group 0. LVEF values are expressed 
as percentage. 
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Figure 8: time course variation of LVEF in group 1. LVEF values are expressed 
as percentage. 
 
Age, body mass index (BMI), body surface, heart rate, systolic and 
diastolic arterial pressure, cardiac damage serum markers (except 
Troponin I peak value significantly higher in group 1) were similar 
between group 0 and 1 (Table 1). 
Correlations between Troponin I peak value and EDV, ESV, EF, 
EDVc, ESVc and EFc were evaluated at t0, t1 and t2; we observed a 
significant correlation between I Troponin peak value and EF at t2    
(p < 0.02) and EFc at t2 (p < 0.05).     
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The same values were compared with intra-myocardial indices and 
showed a significant correlation with the value of strain peak at first 
infarcted region level at t2 (p < 0.01) and with strain rate at second 
infarcted region level at t2 (p < 0.03). 
CKMb peak values were similar between group 0 and group 1; 
nevertheless they correlated with EF at t2 (p < 0.02), EFc at t2           
(p < 0.05) and strain peak of first infarcted region at t2 (p < 0.01).   
Coronary angiography was performed in all study patients. In group 0 
ten patients showed a single-vessel coronary artery disease, while five 
patients showed a two and three-vessel coronary artery disease. We 
observed in 14 patients occlusion of left anterior descending artery 
and in six patients the occlusion of left circumflex artery. Primary PCI 
of “culprit” lesion was performed in all group 0 of patients; we 
completed myocardial revascularization in eight patients with multi-
vessel coronary artery disease during the first week after AMI. In 
group 1, 15 patients showed a single-vessel coronary artery disease, 
while four patients showed a three-vessel coronary artery disease (in 
these patients only PCI of “culprit lesion” was performed). We 
observed in eight patients the occlusion of left anterior descending 
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artery, in eight patients the occlusion of left circumflex artery and in 
three patients the occlusion of right coronary artery. Primary PCI of 
“culprit” lesion was performed in eleven patients, while rescue PCI 
was reserved for eight patients. 
Left ventricular dimensions obtained in M-mode, LVM and         
trans-mitral flow velocity were similar between group 0 and group 1 
at t0 (Table 4).  
Referring to left ventricular volumes and global ejection fraction 
obtained with conventional echocardiography (Table 2) we observed: 
1) EDV did not significantly differ between group 0 and group 1; 2) 
ESV and EF at t0 were respectively higher (p < 0.02) and lower        
(p < 0.02) in group 0, while EF at t2 was higher (p < 0.04) in group 0. 
Analysis of EDV, ESV and EF at t0, t1 and t2 showed an opposite 
behaviour between group 0 and group 1.  
In group 0, EDV showed a not significant reduction, while ESV was 
significantly reduced (p < 0.05) and EF gradually increased (p < 0.01). 
In group 1, EDV and ESV increased (p < 0.04 and p < 0.01 
respectively), while EF showed t1 values significantly lower than t0        
(p < 0.04) and t2 values similar to t1 (p = ns) (Table 2 and table 3). 
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Wall motion score index values showed a significant time-dependent 
reduction (t0 vs t2; 1.64 vs 1.53; p < 0.01) in group 0. Otherwise, in 
group 1 WMSI values gradually increased from t0 to t2 (1.55 vs 1.62; 
p < 0.05) (Table 7 e table 8).  
With “Diogene” we automatically calculated left ventricular volumes 
and ejection fraction (Table 5 e table 6).  
EFc values at t0 were significantly higher in group 1 compared with 
group 0. According to results obtained with conventional 
echocardiography, in group 0 EFc values gradually increased             
(p < 0.04) from t0 to t2, while in group 1 EFc showed t2 values 
significantly lower than t0 (p < 0.04). 
Ejection fraction values, obtained with conventional 
echocardiography, and EFc values, calculated with “Diogene”, 
significantly correlate (p < 0.001) (Figure 9). 
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Figure 9: linear regression analysis for EF and EFc values. 
In group 0, EDVc values were similar at all times, while ESVc values 
gradually decreased (p < 0.05). In group 1, EDVc and ESVc were 
increased since t0 to t2 with consequent left ventricular dilatation and 
dysfunction. 
Correlation between EDV and ESV values, obtained with 
conventional echocardiography and with “Diogene” were statistically 
significant (EDV p < 0.0001; ESV p < 0.001) (Figure 10 and 11).  
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Figure 10: EDV and EDVc values correlation. 
 
 
Figure 11: ESV and ESVc correlation. 
With “Diogene” we studied systolic and diastolic intra-myocardial 
function of left ventricular four areas (two infarcted areas, a peri-
infarcted area and an “healthy” area).  
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All evaluated parameters showed similar values between group 0 and 
group 1.    
In relation to time course variation of every single value, in each 
group, we observed: 
1- First infarcted area (Table 9 and table 10): 
in group 0 strain and strain rate values were constantly similar. S peak 
values gradually decreased (t0 vs t2; 1.87 vs 1.44; p < 0.04), while E 
peak showed a significant reduction at t1 (t0 vs t1; -1.59 vs -0.7          
p < 0.01) with similar values at t1 and t2 (t1 vs t2; -0.7 vs 0.78 p ns); 
A peak was steady. 
In group 1 strain and strain rate values showed a significant reduction 
(t0 vs t2; strain: -16.9 vs -8.74, p < 0.04; strain rate: 0.71 vs 0.37,        
p < 0.05). S peak significantly differed with t1 values lower than t0 (t0 
vs t1; 1.37 vs 1.01; p < 0.05) and a small improvement at t2 (t1 vs t2; 
1.01 vs 1.06; p = ns). E peak and A peak were similar at the three 
evaluation times.  
2- Second infarcted area (Table 11 and table 12): 
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in group 0 strain and strain rate values were similar at the three 
evaluation times. S peak improved (t0 vs t2; 1.46 vs 2.42; p < 0.05), 
while E and A peaks were stable. 
In group 1 strain and strain rate did not significantly differ. S peak       
(t0 vs t2; 2.05 vs 1.17; p < 0.05) decreased and E peak (t0 vs t2; -2.32 
vs -0.58; p < 0.04) gradually improved, while A peak was stable. 
In this area we observed a different behaviour of mean systolic 
velocity between group 0 and group 1.  
3- Peri-infarcted area (Table 13 and table 14): 
in group 0 strain (t0 vs t2; -18.21 vs -21.25; p < 0.05) and strain rate 
(t0 vs t2; 0.56 vs 0.65; p < 0.05) values showed a significant 
improvement. S peak gradually improved (p < 0.05). We observed a 
normalization of diastolic parameters with increase of E peak (t0 vs 
t2; -1.43 vs -1.77; p < 0.05) and reduction of A peak (t0 vs t2; -2.16   
vs -1.28;  p < 0.02).    
In group 1 strain (t0 vs t2; -15.07 vs -25.58; p < 0.03) and strain rate 
(t0 vs t2; 0.88 vs 0.35; p < 0.05) values showed a significant 
improvement. S peak gradually improved (t0 vs t2; 1.78 vs 2.41; p < 
0.05). E peak showed an oscillating time course with t1 levels lower 
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than t0 and a significant increase at t2 (t1 vs t2; -1.1 vs -1.96;              
p < 0.05), while A peak was steady: impairment of diastolic phase 
persisted. 
4- “Healthy” area (Table 15 and table 16): 
in group 0 strain (t0 vs t2; -14.28 vs -21.04; p < 0.05) and S peak (t0 
vs t2; 2.39 vs 3.38; p < 0.05) values were improved. 
In group 1 all intra-myocardial function parameters not significant 
differed at the three evaluation times. 
To evaluate the prognostic burden of strain and strain rate, we studied 
correlations between these values and EDV, ESV and EF values, 
obtained with conventional echocardiography and with “Diogene”. 
We observed in the first infarcted area, a significant correlation 
between peak strain at t0 and ESV value at t2 (p < 0.05) and EFc 
value at t2 (p < 0.05). Another correlation was between peak strain at 
t2 and EF at t2 (p < 0.01).       
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DISCUSSION 
 
End-diastolic and end-systolic volumes of left ventricle obtained with 
conventional two-dimensional echocardiography (Simpson’s rule 
formula) are significantly correlated with the volumes obtained with 
ventriculography (cardiac catheterization) and myocardial 
scintigraphy.  
In this study we compared left ventricular function parameters 
obtained by an expert operator with conventional echocardiography 
and with semi-automatic “Diogene” evaluation. We observed a 
significant correlation between values obtained with these techniques, 
showing the high reliability of semi-automatic method. 
Preliminary partition of the patients in two groups, obtained by 
strength of left ventricular ejection fraction tendency to improve or to 
decrease, was performed with conventional echocardiography and was 
confirmed by the analysis of other important parameters commonly 
employed (Troponin I peak, WMSI, ESV).  
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First of all, patients of group 0, in those we observed an improvement 
of left ventricular ejection fraction and a reduction of ventricular 
volumes, were treated with primary PCI of the “culprit lesion”. This 
event can be explained with a greater effectiveness of primary PCI to 
preserve or to provide a further recovery of left ventricular volumes 
(especially end-systolic volume) and ejection fraction.  
At t0 ESV and EF values significantly differ between group 0 and 
group 1, but they showed a following inverse time course. 
In group 0, ESV and EF, at t0, were respectively higher and lower 
than in group 1. These values inverted at t2; ESV was lower in group 
0 than in group 1, while EF was significantly higher in group 0. 
The results of this study agree with other studies in those major 
predictors of adverse cardiovascular events after acute myocardial 
infarction were end-systolic area and global systolic function of the 
left ventricle22.     
The same data are confirmed by the analisys of WMSI; it shows, since 
t0 to t2, an important reduction in group 0 and a signficant 
improvement in group 1. 
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The original side of the study is the possibility to analyze the intra-
parietal segmental function of left ventricle with the semi-automatic 
approach. It expresses the deformability of evaluated segment (strain) 
and its rate of deformability (strain rate). 
These parameters, calculated at the three evaluation times, are very 
interesting, because they are relatively independent of left ventricular 
pre-load and after-load; moreover they are independent of rotation and 
translation movements of the heart.    
Furthermore “Diogene” provides to evaluate regional deformability of 
left ventricular walls, with the aim to identify ischaemic areas and to 
analyze residual function. 
Semiautomatic evaluation of intra-myocardial function of the left 
ventricular four areas shows as following: 
1- First infarcted area: in both described groups an oscillating but 
substantially stable course of the variables is observed. In group 1 
actually inferior values are recorded, with reference to the 
deformability of the segment, regarding group 0; the strain peak 
clearly reduces. 
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2- Second infarcted area (close to zone 1): one first differentiation in 
the behaviour of the two groups is observed. In the group 0 strain 
values, strain rate, E and A peak are maintained stable in the time, 
while peak S, index of velocity of the movement of myocardial fibers 
in systolic phase, increases meaningfully, indicating a possible 
improvement of the functionality of such segment. A further reduction 
of peak S and E in the group 1 is observed, therefore a further 
worsening of the systolic and active diastolic function of the 
myocardium, that it could suggest an extension of the infarcted zone. 
3- Peri-infarcted area: in both groups an improvement of the indices of 
intramyocardical function with increase of strain, strain rate and S 
peak, even if more emphasized in group 1. This appearing 
contradiction is imputable to the selection procedure of the surveying 
zones; perinfarctual zones have been chosen in some patients of group 
0 that seem to worse ventricular function and, however, also in the 
other zones EF, between t0 and t2, turns out inferior in comparison the 
correspondent value in group 1. However an improvement clearly 
comes true, with trend to normalization, of the diastolic phase in 
group 0, while in group 1 it remains altered.  
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4- “Healthy” area: also in these myocardial segments, not interested 
from the ischemic event, the tendency to improvement of the 
deformability and systolic velocity in group 0 is observed, while in 
group 1 is recorded a substantial stability.  
The more interesting potentiality of the employment of automatic 
techniques is, by far, the possibility to refer to the results of strain 
analyses, executed at t0, as predictive indices of ventricular 
remodelling six days after the acute event.  
Such possibility is the consequence of the existing correlation between 
the peak values of strain in the first infarctual region, where the 
regional EF maintained less than 35%, and the values of EF to t2 and 
those of the end-systolic volume always to t2.  
These considerations allow to employ the indices of strain to evaluate, 
already beginning at t0, patient’s probability to re-enter in the 
categories to greater risk of development of complications of AMI, 
suggesting a more aimed clinical monitoring and  therapy.  
Another important aspect is the meaningful correlation between the 
parameters of left ventricular function  and peak values of troponin I, 
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CK-Mb and WMSI, that constitute important and well demonstrated 
prognostic indices.16,22,43,44 
Peak values of troponin I and CK-Mb show a meaningful correlation 
with the values of strain peak in the first infartuated area at t2 and the 
peak of strain rate in the second infarctuated area at t2. 
 
Limits of the semiautomatic method 
Such method, being strongly innovative but with a rigorous scientific 
background, is influenced by the lack of one definitive validation 
according to standard techniques (ventriculography during cardiac 
catheterism, nuclear magnetic resonance).  
Like all the techniques of automatic survey of the endocardic edge, 
also the technique we propose depends from the acoustic reflectivity 
of the subject.  
At last the method is an off-line operation, that demands more time in 
comparison to an ultrasound scan routinely executed during the stay in 
hospital. 
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CONCLUSIONS 
 
In this study a serial quantitative appraisal of the whole and regional 
left ventricular function has been executed  in an automatic way 
through the employment of the “Diogenes” program . Data obtained 
from elaborations have been punctually compared with those 
corrispective ones obtained from an expert operator by means of 
conventional echordiographic techniques. The reliability of results 
elaborated from Diogenes is demonstrated from high existing 
correlation indices between the parameters of left ventricular function, 
calculated in semiautomatic modality and estimated by operator. 
According to the above-exposed data, “Diogene” program could be 
used to reduce the variability of measures, mainly imputable to the 
operator experience.  
Obviously, our observations need further validation on large-size 
population. 
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Moreover, to confirm prognostic results, it would be of interest to 
extend study validity increasing over time analysis number after one, 
six months and one year after AMI. 
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ABBREVIATIONS 
 
SAP: systolic arterial pressure 
DAP: diastolic arterial pressure  
EDD: left ventricular end-diastolic diameter 
ESD: left ventricular end-systolic diameter 
EDV: left ventricular end-diastolic volume  
ESV: left ventricular end-systolic volume 
EF: left ventricular ejection fraction 
EDVi: left ventricular end-diastolic volume indexed for body surface 
ESVi: left ventricular end-systolic volume indexed for body surface 
FS= fractional shortening 
IVSDD: inter-ventricular septum diastolic diameter 
IVSSD: inter-ventricular septum systolic diameter 
PWDD: posterior wall diastolic diameter 
PWSD: posterior wall systolic diameter 
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LVM: left ventricular mass 
LVMbs: left ventricular mass indexed for body surface 
SV: stroke volume 
HR: heart rate 
IVRT: isovolumetric relaxation time 
TOTDIAST: total diastolic time 
EDVc: left ventricular end-diastolic volume calculated with “Diogene” 
ESVc: left ventricular end-systolic volume calculated with “Diogene” 
EFc: left ventricular ejection fraction calculated with “Diogene” 
WMSI: wall motion score index 
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TABLES 
 
Table 1: clinical and biochemical parameters. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
SAP0 127.5 26.19 127.78 31.83 ns 
SAP1 113.13 10.64 109.67 19.49 ns 
SAP2 110 9.64 108.33 24.75 ns 
DAP0 75 19.46 70 15.71 ns 
DAP1 70 8.45 65.11 15.78 ns 
DAP2 64.38 12.08 66.11 12.44 ns 
Trop I peak 47.15 36.1 85.91 25.04 0.025 
Miogl peak 1887.69 1716.78 1669.87 1242.31 ns 
CKmbpeak 179.33 101.43 266.61 81.18 ns 
HR 69.38 10.32 72.33 14.12 ns 
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Table 2: conventional echocardiographic parameters. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
EDV0 98.5 22.63 85.03 17.18 ns 
EDV1 92.81 26.18 87.1 12.53 ns 
EDV2 90.75 21.01 92.33 15.48 ns 
ESV0 51.75 9.79 38.78 10.37 0.018 
ESV1 45.13 13.97 44.11 7.69 ns 
ESV2 41.38 10 47.22 7.41 ns 
EF0 46.88 4.26 54 6.48 0.017 
EF1 50.75 6.61 49.06 6.88 ns 
EF2 54.38 5.85 49.11 2.57 0.042 
EDVi0 52.19 6.78 46.26 7.12 ns 
EDVi1 49.15 9.49 47.7 6.45 ns 
EDVi2 48.4 7.89 50.26 5.74 ns 
ESVi0 27.59 3.64 21.06 4.97 ns 
ESVi1 24.03 6.37 24.28 4.91 ns 
ESVi2 22.25 4.9 25.77 3.27 ns 
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Table 3: intra-group analysis of conventional echocardiographic 
parameters. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
EDV 0.05 ns 0.04 0.04 ns ns 0.04 0.04 
ESV 0.05 ns 0.04 0.05 ns ns 0.01 0.01 
EF ns ns 0.01 0.01 0.05 ns 0.04 0.04 
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Table 4: conventional echocardiographic performed at t0. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
EDD 5.15 0.54 5.52 0.39 ns 
ESD 3.56 0.64 3.65 0.37 ns 
FS 31.03 9.11 35.1 5.19 ns 
IVSSD 1.31 0.14 1.29 0.19 ns 
IVSDD 1.04 0.25 0.97 0.16 ns 
PWSD 1.44 0.32 1.4 0.18 ns 
PWDD 0.98 0.12 0.93 0.12 ns 
LVMbs 126.31 44.7 131.02 28.89 ns 
SV 73.3 22.5 92.27 15.78 ns 
E peak 0.68 0.15 0.65 0.11 ns 
A peak 0.71 0.17 0.8 0.17 ns 
E/A ratio 0.99 0.33 0.84 0.24 ns 
IVRT 74.25 16.61 62.89 19.81 ns 
TOTDIAST 443.25 111.21 419.11 75.34 ns 
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Table 5: left ventricular systolic function calculated with 
“Diogene”. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
EDVc0 94.72 22.9 85.74 15.4 ns 
EDVc1 92.88 19.87 82.84 19.05 ns 
EDVc2 96.4 11.86 100.86 19.8 ns 
ESVc0 61.23 16.21 49.55 10.65 ns 
ESVc1 55.98 13.76 56.68 14.22 ns 
ESVc2 54.4 6.9 60.28 11.99 ns 
EFc0 35.75 6.9 42.38 5.83 0.05 
EFc1 40.38 8.43 40.38 5.29 ns 
EFc2 43.75 7.55 36.13 4.19 0.04 
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Table 6: intra-group analysis of left ventricular systolic function 
calculated with “Diogene”. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
EDV ns ns ns ns ns 0.05 ns 0.05 
ESV ns ns 0.05 0.05 ns ns 0.05 0.05 
EF ns ns 0.03 0.03 ns ns 0.05 0.05 
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Table 7: wall motion score index. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
WMSI0 1.64 0.23 1.55 0.15 ns 
WMSI1 1.63 0.24 1.56 0.16 ns 
WMSI2 1.53 0.24 1.62 0.27 ns 
 
 
 
Table 8: intra-group analysis of WMSI. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
WMSI ns 0.05 0.01 0.02 ns 0.05 0.05 0.05 
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Table 9: intra-myocardial function parameters calculated with 
“Diogene” of the first infarcted area. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
Strain peak 0 -12.2 7.88 -16.9 8.93 ns 
Strain peak 1 -16.99 8.21 -7.54 6.14 ns 
Strain peak 2 -18.55 9.07 -8.74 7.37 ns 
Strain rate 0 0.64 0.27 0.71 0.54 ns 
Strain rate 1 0.83 0.79 0.55 0.62 ns 
Strain rate 2 0.51 0.49 0.37 0.22 ns 
S peak 0 1.87 1.45 1.37 1.33 ns 
S peak 1 1.67 1.59 1.01 1.05 ns 
S peak 2 1.44 1.39 1.06 1.64 ns 
E peak 0 -1.59 1.19 -0.64 0.68 ns 
E peak 1 -0.7 0.76 -0.69 0.76 ns 
E peak 2 -0.78 2 -0.72 0.91 ns 
A peak 0 -1.82 1.44 -2 2.95 ns 
A peak 1 -1.28 1.29 -0.87 1.06 ns 
A peak 2 -2.14 3.1 -2.44 2.97 ns 
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Table 10: intra-group analysis of intra-myocardial function 
parameters calculated with “Diogene” of the first infarcted area. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
S.peak ns ns ns ns 0.04 ns 0.05 0.04 
S.rate ns ns ns ns ns ns 0.05 0.05 
Speak ns ns 0.04 0.04 0.05 ns 0.05 0.05 
Epeak 0.01 ns 0.01 0.01 ns ns ns ns 
Apeak ns ns ns ns ns ns ns ns 
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Table 11: intra-myocardial function parameters calculated with 
“Diogene” of the second infarcted area. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
Strain peak 0 -20.9 7.77 -19.05 4.35 ns 
Strain peak 1 -20.1 9.85 -16.4 6.08 ns 
Strain peak 2 -19.27 6.18 -17.36 4.48 ns 
Strain rate 0 0.76 0.63 0.58 0.55 ns 
Strain rate 1 0.93 0.49 0.62 0.36 ns 
Strain rate 2 0.89 1.12 0.89 0.88 ns 
S peak 0 1.46 1.47 2.05 1.99 ns 
S peak 1 2.31 1.57 1.78 1.45 ns 
S peak 2 2.42 2.23 1.17 1.39 ns 
E peak 0 -1.99 2.14 -2.32 1.57 ns 
E peak 1 -1.67 1.03 -0.76 0.98 ns 
E peak 2 -1.29 1.32 -0.58 1.29 ns 
A peak 0 -2.95 3.49 -3.21 3.45 ns 
A peak 1 -2.24 1.87 -2.26 2.52 ns 
A peak 2 -1.3 1.24 -1.46 1.35 ns 
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Table 12: intra-group analysis of intra-myocardial function 
parameters calculated with “Diogene” of the second infarcted 
area. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
S.peak ns ns ns ns ns ns ns ns 
S.rate ns ns ns ns ns ns ns ns 
Speak 0.05 ns 0.05 0.05 ns 0.05 0.05 0.05 
Epeak ns ns ns ns 0.03 ns 0.04 0.04 
Apeak ns ns ns ns ns ns ns ns 
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Table 13: intra-myocardial function parameters calculated with 
“Diogene” of the peri-infarcted area. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
Strain peak 0 -18.21 13.49 -15.07 11.35 ns 
Strain peak 1 -16.04 10.01 -14.7 6.38 ns 
Strain peak 2 -21.25 4.26 -25.58 13.63 ns 
Strain rate 0 0.56 0.23 0.88 0.5 ns 
Strain rate 1 0.55 0.4 1.13 1.02 ns 
Strain rate 2 0.95 0.55 1.35 0.98 ns 
S peak 0 2.12 1.67 1.78 0.93 ns 
S peak 1 1.89 1.35 2.24 1.39 ns 
S peak 2 2.19 0.97 2.41 0.6 ns 
E peak 0 -1.43 1.23 -2.19 1.6 ns 
E peak 1 -1.58 1.21 -1.1 0.97 ns 
E peak 2 -1.77 1.48 -1.96 1.33 ns 
A peak 0 -2.16 2.09 -2.31 1.28 ns 
A peak 1 -2.33 1.84 -1.76 2.19 ns 
A peak 2 -1.28 0.96 -1.96 1.27 ns 
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Table 14: intra-group analysis of intra-myocardial function 
parameters calculated with “Diogene” of the peri-infarcted area. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
S.peak ns ns 0.05 0.05 ns 0.04 0.02 0.03 
S.rate ns 0.05 0.05 0.05 0.05 ns 0.05 0.05 
Speak ns 0.05 ns 0.05 ns ns 0.05 0.05 
Epeak ns ns 0.05 0.05 0.04 0.05 ns 0.05 
Apeak ns 0.02 ns 0.02 ns ns ns ns 
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Table 15: intra-myocardial function parameters calculated with 
“Diogene” of the “healthy” area. 
Group 0 Group 1 
 
Mean SD Mean SD 
 
p < 0.05 
Strain peak 0 -14.28 9.54 -19.48 10.41 ns 
Strain peak 1 -25.43 7.75 -19.23 11.2 ns 
Strain peak 2 -21.04 6.63 -28.66 16.8 ns 
Strain rate 0 0.91 0.99 1.04 1.49 ns 
Strain rate 1 1.34 1.11 1.06 1.03 ns 
Strain rate 2 1.01 0.48 0.91 0.64 ns 
S peak 0 2.39 0.71 2.99 0.88 ns 
S peak 1 3.37 1.81 3.15 1.61 ns 
S peak 2 3.38 1.27 3.87 2.2 ns 
E peak 0 -2.16 1.49 -2.24 0.95 ns 
E peak 1 -2.09 0.9 -2.01 1.62 ns 
E peak 2 -1.93 1.43 -2.99 2.52 ns 
A peak 0 -2.96 1.79 -4.03 3.6 ns 
A peak 1 -3.9 1.77 -2.35 1.52 ns 
A peak 2 -4.51 2.44 -2.86 1.89 ns 
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Table 16: intra-group analysis of intra-myocardial function 
parameters calculated with “Diogene” of the “healthy” area. 
 
Group 0 Group 1 
p 0-1 1-2 0-2 glob 0-1 1-2 0-2 glob 
S.peak 0.05 ns 0.05 0.05 ns ns ns ns 
S.rate ns ns ns ns ns ns ns ns 
Speak 0.05 ns 0.05 0.05 ns ns ns ns 
Epeak ns ns ns ns ns ns ns ns 
Apeak ns ns ns ns ns ns ns ns 
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